Two Sigma Securities’s Shuttle Pharmaceuticals SHPH Stock Holding History

Two Sigma Securities’s Portfolio SHPH Stock Details SHPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-89	Closed	-$8.63K	–	2019
2025 Q1	$8.63K	Buy	+89	New	+$14.5K	﹤0.01%	1253
2024 Q3	–	Sell	-21	Closed	-$16.9K	–	3552
2024 Q2	$16.9K	Buy	+21	New	+$17.8K	﹤0.01%	2733
2023 Q1	–	Sell	-8	Closed	-$32.3K	–	3202
2022 Q4	$32.3K	Buy	+8	New	+$38.9K	﹤0.01%	2218

Other funds holding SHPH

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Two Sigma Securities's SHPH Position: Q2 2025 in Review

Two Sigma Securities sold out of Shuttle Pharmaceuticals (SHPH) in Q2 2025, closing a stake of 89 shares — an estimated $8.63K sold.

Two Sigma Securities first reported a position in SHPH in Q4 2022 and held it in 3 quarters. The position peaked at $32.3K in Q4 2022. 3 funds tracked by Wall St. Rank hold SHPH as of Q2 2025.

Two Sigma Securities reported no remaining Shuttle Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
Two Sigma Securities sold 89 Shuttle Pharmaceuticals shares in Q2 2025, an estimated $8.63K.
Two Sigma Securities first reported a position in Shuttle Pharmaceuticals in Q4 2022 and held it in 3 quarters.
Two Sigma Securities's Shuttle Pharmaceuticals position peaked at $32.3K in Q4 2022.
3 funds tracked by Wall St. Rank held Shuttle Pharmaceuticals as of Q2 2025.

Based on Two Sigma Securities's 13F filing for Q2 2025, filed 14 Aug 2025.